Results 131 to 140 of about 118,583,499 (297)
Acquired hemophilia A: emerging treatment options
, 2015 Maissaa Janbain,1 Cindy A Leissinger,1 Rebecca Kruse-Jarres2 1Louisiana Center for Bleeding and Clotting Disorders, Tulane University Medical Center, New Orleans, LA, USA; 2Washington Center for Bleeding Disorders, Blood Works NW, Seattle, WA, USA ...
Janbain M, Kruse-Jarres R, Leissinger CA
core
Haemophilia, EarlyView.ABSTRACT Introduction Emicizumab is a bispecific antibody approved for prophylaxis in people with haemophilia A (PwHA). Aim To describe from the physician perspective the characteristics and treatment experiences of PwHA receiving emicizumab. Methods The Adelphi Real World Haemophilia Disease Specific Programme is a cross‐sectional, retrospective data ...
Michael Recht +7 more
wiley +1 more source
Hemophilia A: Pathophysiology and Treatment Strategies [PDF]
, 2014 Hemophilia is a sex-linked recessive coagulation disorder that varies in severity. The implications and complications of hemophilia can be life threatening; pathology is usually diagnosed during childhood and adequate management is essential in ...
Dinneen, Daniel
core
Haemophilia, EarlyView.ABSTRACT Background Evidence on the impact of emicizumab on joint health, particularly hypertrophic synovium (HS), remains limited. Objectives To evaluate changes in HS, using point‐of‐care ultrasound and clinical examination in People with Haemophilia (PwH) switching from replacement therapy to emicizumab.
Matteo Nicola Dario Di Minno +8 more
wiley +1 more source
This Guide is written for Hemophilia Treatment Center (HTC) providers who have primary responsibility for educating families about hemophilia. It accompanies the Basic Concepts of Hemophilia: A Self-study and Planning Workbook for Families with a New ...
core
Risk of Postpartum Hemorrhage in Women With Von Willebrand Disease: A Real‐World Data Analysis
Haemophilia, EarlyView.ABSTRACT Introduction Women with von Willebrand disease (VWD) are at increased risk for postpartum hemorrhage (PPH), but contemporary United States data on maternal outcomes and real‐world peripartum treatment patterns are limited. Aim To evaluate maternal outcomes associated with claims‐recorded VWD in a national claims cohort and describe exploratory
Mayank Patel +4 more
wiley +1 more source
Strategies to encourage physical activity in patients with hemophilia to improve quality of life
, 2016 Miwa Goto,1 Hideyuki Takedani,2 Kazuhiko Yokota,1 Nobuhiko Haga3 1Rehabilitation Center, The University of Tokyo Hospital, 2Department of Joint Surgery, Research Hospital of the Institute of Medical Science, The University of Tokyo, 3Department of ...
Haga N, Yokota K, Goto M, Takedani H
core
Living With Factor VII Deficiency—A Mixed Methods Study
Haemophilia, EarlyView.ABSTRACT Background Factor VII deficiency (FVIID) is a rare autosomal recessive disorder, resulting in potentially unpredictable and life‐threatening bleeding. The prevalence of symptomatic patients is 1 in 300,000. Treatment is mostly given following bleeding, but those with the lowest levels may be offered prophylaxis.
Simon Fletcher +3 more
wiley +1 more source
Extracorporeal lithotripsy in patients with hemophilia
, 1988 Two hemophiliac patients with nephrolithiasis were treated with extracorporeal lithotripsy. Both patients were followed up by the 2nd Hemophilia Center of Athens. One is registered as severe hemophilia A and the other one suffers from hemophilia B.
Becopoulos, T. +4 more
core +1 more source